Patient-derived ependymoma and medulloblastoma tumoroids: generation, biobanking and drug screening.

Lago C, Leva G, Kool M, Miele E, Tiberi L

Open source

DOI
10.1038/s41596-026-01347-9
Published
2026 Sep
Container
Nature protocols
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41596-026-01347-9,
  title = {Patient-derived ependymoma and medulloblastoma tumoroids: generation, biobanking and drug screening.},
  author = {Lago C and Leva G and Kool M and Miele E and Tiberi L},
  year = {2026},
  journal = {Nature protocols},
  doi = {10.1038/s41596-026-01347-9},
  url = {https://doi.org/10.1038/s41596-026-01347-9}
}

RIS

TY  - JOUR
TI  - Patient-derived ependymoma and medulloblastoma tumoroids: generation, biobanking and drug screening.
AU  - Lago C
AU  - Leva G
AU  - Kool M
AU  - Miele E
AU  - Tiberi L
PY  - 2026
JO  - Nature protocols
DO  - 10.1038/s41596-026-01347-9
UR  - https://doi.org/10.1038/s41596-026-01347-9
ER  - 

APA

C, L., G, L., M, K., E, M., & L, T. (2026). Patient-derived ependymoma and medulloblastoma tumoroids: generation, biobanking and drug screening.. Nature protocols. https://doi.org/10.1038/s41596-026-01347-9

Source records